China Universal Asset Management Company’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.34M Sell
33,835
-1,332
-4% -$195K 0.38% 54
2026
Q1
$3.42M Buy
35,167
+1,166
+3% +$118K 0.26% 70
2025
Q4
$2.71M Sell
34,001
-8,766
-20% -$575K 0.21% 84
2025
Q3
$2M Sell
42,767
-34,644
-45% -$1.36M 0.17% 112
2025
Q2
$2.85M Sell
77,411
-12,551
-14% -$482K 0.27% 79
2025
Q1
$3.18M Buy
89,962
+27,982
+45% +$1.14M 0.3% 72
2024
Q4
$2.71M Buy
61,980
+29,853
+93% +$1.51M 0.25% 84
2024
Q3
$1.46M Buy
32,127
+12,744
+66% +$555K 0.16% 111
2024
Q2
$752K Sell
19,383
-12,254
-39% -$458K 0.11% 124
2024
Q1
$1.02M Buy
31,637
+12,696
+67% +$376K 0.13% 127
2023
Q4
$543K Buy
18,941
+16,139
+576% +$388K 0.11% 141
2023
Q3
$77.6K Buy
2,802
+1,409
+101% +$41.8K 0.02% 210
2023
Q2
$37.3K Buy
1,393
+167
+14% +$4.1K 0.01% 221
2023
Q1
$26.6K Buy
1,226
+324
+36% +$7.98K 0.01% 194
2022
Q4
$21.5K Buy
902
+81
+10% +$1.72K 0.01% 170
2022
Q3
$16K Buy
+821
New +$18K 0.01% 167

Other funds holding RVMD

China Universal Asset Management Company's RVMD Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Revolution Medicines (RVMD) stake by 3.8% in Q2 2026, selling an estimated $195K and leaving 33,835 shares worth $6.34M. The position accounts for 0.38% of the portfolio, ranked #54.

China Universal Asset Management Company first reported a position in RVMD in Q3 2022 and has held it in 16 quarters since. 154 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • China Universal Asset Management Company held 33,835 shares of Revolution Medicines worth $6.34M as of Q2 2026.
  • China Universal Asset Management Company sold 1,332 Revolution Medicines shares in Q2 2026, an estimated $195K.
  • Revolution Medicines made up 0.38% of China Universal Asset Management Company's portfolio in Q2 2026, its #54 holding.
  • China Universal Asset Management Company first reported a position in Revolution Medicines in Q3 2022 and has held it in 16 quarters since.
  • 154 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.